← Back to patent-cliff list
Biperiden Hydrochloride
Tier C — Watch / tradeBiperiden Hydrochloride
AbbVie
Originator
1959
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：mAChRs
Brand：Akineton
Indications (approved)：创伤后癫痫, Traumatic brain injury, 脑损伤, Parkinson's disease, Cocaine addiction
Regional status
US
Withdrawn
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Biperiden Hydrochloride?
Approved indications include: 创伤后癫痫, Traumatic brain injury, 脑损伤, Parkinson's disease, Cocaine addiction.
When does the Biperiden Hydrochloride patent expire?
No public expiry year is available for Biperiden Hydrochloride yet; this page updates once verified.
How do I get a quote for Biperiden Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-19